## **Core Concept**
Warfarin toxicity occurs due to the excessive anticoagulant effect of warfarin, a vitamin K antagonist used to prevent and treat thrombotic disorders. The management of warfarin toxicity involves reversing the anticoagulant effect. This can be achieved by administering agents that counteract the effects of warfarin on coagulation.

## **Why the Correct Answer is Right**
The correct answer, **C. Vitamin K1 (Phylloquinone)**, is the drug of choice for warfarin toxicity because it directly counteracts the mechanism of warfarin. Warfarin inhibits the synthesis of vitamin K-dependent clotting factors (II, VII, IX, and X) in the liver. Vitamin K1 supplementation provides the necessary substrate for the gamma-carboxylation of these clotting factors, effectively reversing the anticoagulant effect of warfarin.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Fresh frozen plasma (FFP) can rapidly correct coagulopathy by providing the deficient clotting factors but is usually reserved for severe bleeding or when a rapid reversal is needed. It does not address the underlying cause and carries risks like volume overload and transfusion reactions.
- **Option B:** Protamine sulfate is used to reverse the effects of heparin, not warfarin. It works by binding to heparin and forming a stable complex that removes heparin from the circulation, thereby neutralizing its anticoagulant effect.
- **Option D:** Platelet transfusion may be considered in cases of thrombocytopenia or platelet dysfunction but is not indicated for the treatment of warfarin toxicity, which primarily affects the coagulation cascade rather than platelet function or count.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that for mild to moderate warfarin overdose without bleeding, oral vitamin K1 is the preferred initial treatment. In cases of severe bleeding or significantly elevated INR, both vitamin K1 and fresh frozen plasma may be used together.

## **Correct Answer:** C. Vitamin K1 (Phylloquinone)